Full View

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia

CR Rausch, CD DiNardo, A Maiti, NJ Jammal… - Cancer, 2021 - Wiley Online Library
Background Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine
improves survival in patients aged≥ 75 years with newly diagnosed acute myeloid leukemia …
被引用次数：40 相关文章

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia

CR Rausch, CD DiNardo, A Maiti, NJ Jammal… - Cancer, 2021 - pubmed.ncbi.nlm.nih.gov
Background Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine
improves survival in patients aged≥ 75 years with newly diagnosed acute myeloid leukemia …

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia

CR Rausch, CD DiNardo, A Maiti, NJ Jammal… - Cancer, 2021 - einstein.elsevierpure.com
Background: Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine
improves survival in patients aged≥ 75 years with newly diagnosed acute myeloid leukemia …

[引用][C] Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia

CR Rausch, NJ Jammal, KR Marx, JM Savoy… - Cancer, 2021 - elibrary.ru

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.

CR Rausch, CD DiNardo, A Maiti… - Cancer …, 2021 - search.ebscohost.com
Background: Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine
improves survival in patients aged≥ 75 years with newly diagnosed acute myeloid leukemia …

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia

CR Rausch, CD DiNardo, A Maiti… - …, 2021 - mdanderson.elsevierpure.com
Background: Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine
improves survival in patients aged≥ 75 years with newly diagnosed acute myeloid leukemia …

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia

CR Rausch, CD DiNardo, A Maiti, NJ Jammal… - Cancer, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> Venetoclax (VEN) combined
with the hypomethylating agent (HMA) azacitidine improves survival in patients aged≥ 75 …

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.

CR Rausch, CD DiNardo, A Maiti, NJ Jammal… - Cancer, 2021 - europepmc.org
Background Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine
improves survival in patients aged≥ 75 years with newly diagnosed acute myeloid leukemia …

Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.

CR Rausch, CD Dinardo, A Maiti, NJ Jammal… - 2021 - cabidigitallibrary.org
Background: Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine
improves survival in patients aged≥ 75 years with newly diagnosed acute myeloid leukemia …
[HTML] nih.gov

[HTML][HTML] Duration of Cytopenias with Concomitant Venetoclax and Azole Antifungals in Acute Myeloid Leukemia

CR Rausch, CD DiNardo, A Maiti, NJ Jammal… - Cancer, 2021 - ncbi.nlm.nih.gov
Background: Venetoclax (VEN) combined with the hypomethylating agent (HMA) azacitidine
improves survival in patients≥ 75 years of age with newly diagnosed acute myeloid …